Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCLPIII: FC vs FCR in Untreated Mantle Cell Lymphoma
NCT00641095Phase 3Completed
- Sponsor
- University College London
- Start
- Dec 2006
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of rituximab in mantle cell lymphoma (MCL), sponsored by University College London. Started Dec 2006; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00641095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641095.